Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $21
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $24 to $21.
Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $24 to $21.